Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,102
Closed -$38K 1530
2022
Q4
$38K Hold
1,102
﹤0.01% 1449
2022
Q3
$34K Hold
1,102
﹤0.01% 1465
2022
Q2
$41K Buy
+1,102
New +$42.7K ﹤0.01% 1454
2022
Q1
Sell
-1,610
Closed -$78K 1306
2021
Q4
$78K Sell
1,610
-3,684
-70% -$186K ﹤0.01% 1206
2021
Q3
$294K Hold
5,294
﹤0.01% 1000
2021
Q2
$287K Sell
5,294
-1,735
-25% -$95.2K ﹤0.01% 1030
2021
Q1
$394K Hold
7,029
﹤0.01% 927
2020
Q4
$306K Hold
7,029
﹤0.01% 954
2020
Q3
$273K Buy
+7,029
New +$309K ﹤0.01% 924
2020
Q1
Sell
-6,147
Closed -$255K 1430
2019
Q4
$255K Buy
+6,147
New +$259K ﹤0.01% 1255
2016
Q2
Sell
-762
Closed -$14K 1315
2016
Q1
$14K Sell
762
-3,366
-82% -$63.3K ﹤0.01% 1239
2015
Q4
$84K Hold
4,128
﹤0.01% 1129
2015
Q3
$90K Sell
4,128
-4,852
-54% -$114K ﹤0.01% 1142
2015
Q2
$210K Sell
8,980
-2,974
-25% -$74.6K ﹤0.01% 1116
2015
Q1
$311K Buy
11,954
+3,658
+44% +$87.1K ﹤0.01% 1017
2014
Q4
$183K Buy
8,296
+5,296
+177% +$112K ﹤0.01% 1222
2014
Q3
$54K Hold
3,000
﹤0.01% 1206
2014
Q2
$64K Hold
3,000
﹤0.01% 1252
2014
Q1
$68K Sell
3,000
-1,201
-29% -$29.3K ﹤0.01% 1183
2013
Q4
$102K Buy
4,201
+3,000
+250% +$70.7K ﹤0.01% 1135
2013
Q3
$29K Hold
1,201
﹤0.01% 1214
2013
Q2
$24K Buy
+1,201
New +$30.1K ﹤0.01% 1206

Other funds holding SRDX

KBC Group's SRDX Position: Q1 2023 in Review

KBC Group sold out of Surmodics (SRDX) in Q1 2023, closing a stake of 1,102 shares — an estimated $38K sold.

KBC Group first reported a position in SRDX in Q2 2013 and held it in 22 quarters. The position peaked at $394K in Q1 2021. 119 funds tracked by Wall St. Rank hold SRDX as of Q1 2023.

  • KBC Group reported no remaining Surmodics position as of Q1 2023 after selling out during the quarter.
  • KBC Group sold 1,102 Surmodics shares in Q1 2023, an estimated $38K.
  • KBC Group first reported a position in Surmodics in Q2 2013 and held it in 22 quarters.
  • KBC Group's Surmodics position peaked at $394K in Q1 2021.
  • 119 funds tracked by Wall St. Rank held Surmodics as of Q1 2023.

Based on KBC Group's 13F filing for Q1 2023, filed 4 May 2023.